Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Microbes Infect ; 25(5): 105102, 2023 06.
Article in English | MEDLINE | ID: mdl-36708871

ABSTRACT

To persist in the blood circulation and to be available for mosquitoes, Plasmodium falciparum gametocytes modify the deformability and the permeability of their erythrocyte host via cyclic AMP (cAMP) signaling pathway. Cyclic nucleotide levels are tightly controlled by phosphodiesterases (PDE), however in Plasmodium these proteins are poorly characterized. Here, we characterize the P. falciparum phosphodiesterase delta (PfPDEδ) and we investigate its role in the cAMP signaling-mediated regulation of gametocyte-infected erythrocyte mechanical properties. Our results revealed that PfPDEδ is a dual-function enzyme capable of hydrolyzing both cAMP and cGMP, with a higher affinity for cAMP. We also show that PfPDEδ is the most expressed PDE in mature gametocytes and we propose that it is located in parasitophorous vacuole at the interface between the host cell and the parasite. We conclude that PfPDEδ is the master regulator of both the increase in deformability and the inhibition of channel activity in mature gametocyte stages, and may therefore play a crucial role in the persistence of mature gametocytes in the bloodstream.


Subject(s)
Malaria, Falciparum , Plasmodium falciparum , Animals , Plasmodium falciparum/physiology , Phosphoric Diester Hydrolases , Malaria, Falciparum/parasitology , Erythrocytes/parasitology , Signal Transduction
2.
Front Cell Infect Microbiol ; 12: 883759, 2022.
Article in English | MEDLINE | ID: mdl-35694548

ABSTRACT

The persistence of erythrocytes infected with Plasmodium falciparum gametocytes in the bloodstream is closely related to the modulation of their mechanical properties. New drugs that increase the stiffness of infected erythrocytes may thus represent a novel approach to block malaria parasite transmission. The phosphodiesterase inhibitor tadalafil has been shown to impair the ability of infected erythrocytes to circulate in an in vitro model for splenic retention. Here, we used a humanized mouse model to address in vivo the effect of tadalafil on the circulation kinetics of mature gametocyte-infected erythrocytes. We show that stiff immature gametocyte-infected erythrocytes are retained in the spleen of humanized mice at rates comparable to that of the in vitro model. Accordingly, tadalafil-induced stiffening of mature gametocyte-infected erythrocytes impairs their circulation in the bloodstream and triggers their retention by the spleen. These in vivo results validate that tadalafil is a novel drug lead potentially capable of blocking malaria parasite transmission by targeting GIE mechanical properties.


Subject(s)
Malaria, Falciparum , Plasmodium falciparum , Animals , Malaria, Falciparum/drug therapy , Malaria, Falciparum/parasitology , Mice , Phosphodiesterase Inhibitors , Spleen , Tadalafil/pharmacology
3.
Mol Biochem Parasitol ; 244: 111392, 2021 07.
Article in English | MEDLINE | ID: mdl-34171456

ABSTRACT

Plasmodium falciparum gametocytes modify the mechanical properties of their erythrocyte host to persist for several weeks in the blood circulation and to be available for mosquitoes. These changes are tightly regulated by the plasmodial phosphodiesterase delta that decreases both the stiffness and the permeability of the infected host cell. Here, we address the effect of the phosphodiesterase inhibitor tadalafil on deformability and permeability of gametocyte-infected erythrocytes. We show that this inhibitor drastically increases isosmotic lysis of gametocyte-infected erythrocytes and impairs their ability to circulate in an in vitro model for splenic retention. These findings indicate that tadalafil represents a novel drug lead potentially capable of blocking malaria parasite transmission by impacting gametocyte circulation.


Subject(s)
Cyclic Nucleotide Phosphodiesterases, Type 5/genetics , Gametogenesis/drug effects , Life Cycle Stages/drug effects , Phosphodiesterase 5 Inhibitors/pharmacology , Plasmodium falciparum/drug effects , Protozoan Proteins/antagonists & inhibitors , Tadalafil/pharmacology , Biomechanical Phenomena , Cell Membrane Permeability/drug effects , Cyclic Nucleotide Phosphodiesterases, Type 5/metabolism , Erythrocyte Deformability/drug effects , Erythrocytes/drug effects , Erythrocytes/parasitology , Erythrocytes/ultrastructure , Female , Gene Expression , Host-Parasite Interactions/drug effects , Host-Parasite Interactions/genetics , Humans , Life Cycle Stages/genetics , Male , Plasmodium falciparum/enzymology , Plasmodium falciparum/genetics , Plasmodium falciparum/growth & development , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Reproduction, Asexual/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL